Early diagnosis of prostate cancer (PCa) has increased in recent decades, and themortality rate has decreased in countries where the prostate-specific antigen (PSA)blood test was introduced at an early stage [1]. This evidence concerns the gene KLK3 and Familial prostate cancer.